Skip to main content
See every side of every news story
Published loading...Updated

Gilead Sciences' (GILD) Overweight Rating Reaffirmed at Cantor Fitzgerald

Summary by marketbeat.com
Cantor Fitzgerald reiterated an "overweight" rating and issued a $155.00 target price on shares of Gilead Sciences in a research note on Monday.

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

247wallst.com broke the news in New York, United States on Monday, July 6, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal